Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolterodine and gabapentin for reduction of post-PCNL pain and discomfort
IRCT201204066504N3Phase 4Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tolterodine and gabapentin in nephrolithiasis, sponsored by Iran University of Medical Sciences. Started Mar 2016; status: completed.
02
Drugs
tolterodinegabapentin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on IRCT201204066504N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201204066504N3.